Cases & Deals

Sterling Biotech restructures $134.5 million of its outstanding Zero Coupon Convertible Bonds

Clients Sterling Biotech Limited

Jones Day advised Sterling Biotech Limited, a manufacturer of pharmaceutical products, on the restructuring of $134.5 million of its outstanding Zero Coupon Convertible Bonds due 2012, including the underlying redemption premium, in a cashless exchange offer for $205 million of Zero Coupon Compulsorily Convertible Bonds due 2019.